Marlboro Maker Invests $1.7 Billion in Cannabis

The cannabis industry announced a groundbreaking $1.7 billion megadeal with big tobacco that has the sector on the upswing last week.

Marlboro maker Altria Group (MO), one of the largest tobacco companies in the world, announced a $1.7 billion investment in Cronos Group (CRON), one of Canada’s largest cannabis companies.

Here are some more details from Bloomberg.

Altria has agreed to take a 45 percent stake in Toronto-based marijuana producer Cronos Group Inc., marking a major tobacco company’s first foray into cannabis. It has the option to take majority control in the future.

With U.S. smoking rates falling fast, Richmond, Virginia-based Altria is under pressure to find new avenues to expand. Marijuana is now allowed in an increasing number of states but is still illegal on the federal level in the U.S. That makes Canada, which legalized recreational use in October, a large laboratory for the nascent industry.

“We believe cannabis is an excellent strategic fit for tobacco,” Jefferies analyst Owen Bennett said in a research note earlier this week. It’s a logical fit, because “big tobacco knows how to cultivate crop, knows how to deal with regulators, they are at the forefront of vaporization technology, and they also arguably have less reputational risk than other fast-moving consumer goods,” he said.

The good news gave Cronos a nice boost – shares jumped 25% and settled just shy of the 52-week high. Continue reading "Marlboro Maker Invests $1.7 Billion in Cannabis"

Is This Canadian Cannabis IPO The Next Big Winner

Analysis originally distributed on May 31, 2018 By: Michael Vodicka of Cannabis Stock Trades

Cannabis IPOs have a proven history of delivering big returns in a short amount of time.

Medreleaf (LEAF) is a great example.

Medreleaf became the largest Canadian cannabis IPO ever in June 2017. Investors were eager to buy and shares quickly began rising.

Less than 12 months later, shares are up 275% from the IPO price.

US cannabis companies

Today – I see this same cycle repeating itself.

One of the largest US cannabis companies just began trading on the Canadian Stock Exchange – and much like Medreleaf – I am expecting good things. Continue reading "Is This Canadian Cannabis IPO The Next Big Winner"

My Plan For Another 30% Gain In 5 Days

Analysis originally distributed on March 7, 2018 By: Michael Vodicka of Cannabis Stock Trades

The Canadian cannabis sector scored another blockbuster win last week - and it led to a quick 30% gain for one of Canada's most promising young cannabis companies. If you missed the recent pop higher don't worry - I see this same pattern repeating itself at least a few more times in the next three months. Here's what is going on.

Cronos Group (CRON) is one of Canada's largest and most promising cannabis companies. Shares began trading on the Toronto Venture Stock Exchange in December of 2014. Since then, Cronos has delivered huge gains to shareholders, jumping more than 1400% from its IPO price of $.80.

That impressive performance helped Cronos make history last week when it became the first ever Canadian cannabis producer to trade on the US-based NASDAQ stock exchange. Continue reading "My Plan For Another 30% Gain In 5 Days"